Henrik Hasseldam

Henrik Hasseldam

Associate Professor


  1. 2005
  2. CEP-11004, an inhibitor of the SAPK/JNK pathway, reduces TNF-alpha release from lipopolysaccharide-treated cells and mice.

    Ciallella, J. R., Saporito, M., Lund, S., Leist, M., Hasseldam, Henrik, McGann, N., Smith, C. S., Bozyczko-Coyne, D. & Flood, D. G., 2005, In: European Journal of Pharmacology. 515, 1-3, p. 179-87 8 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Inhibition of microglial inflammation by the MLK inhibitor CEP-1347.

    Lund, S., Porzgen, P., Mortensen, A. L., Hasseldam, Henrik, Bozyczko-Coyne, D., Morath, S., Hartung, T., Bianchi, M., Ghezzi, P., Bsibsi, M., Dijkstra, S. & Leist, M., 2005, In: Journal of Neurochemistry. 92, 6, p. 1439-51 12 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

ID: 11368